Sign In
Buy SAN
$14.10
-0.0100 (-0.0709%)
At Close: Jul 31, 2026
Communiqué de presse: Dupixent® (dupilumab), premier et seul médicament ciblé approuvé par la Commission européenne pour le traitement de l’œsophagite à éosinophiles
06:00am, Monday, 30'th Jan 2023 GlobeNewswire Inc.
Dupixent® (dupilumab), premier et seul médicament ciblé approuvé par la Commission européenne pour le traitement de l’œsophagite à éosinophiles
Press Release: Dupixent® (dupilumab) approved by European Commission as the first and only targeted medicine indicated for eosinophilic esophagitis
06:00am, Monday, 30'th Jan 2023 GlobeNewswire Inc.
Dupixent® (dupilumab) approved by European Commission as the first and only targeted medicine indicated for eosinophilic esophagitis
Press Release: Dupixent® (dupilumab) recommended for expanded EU approval by the CHMP to treat children as young as six months old with severe atopic dermatitis
06:00am, Friday, 27'th Jan 2023 GlobeNewswire Inc.
Dupixent® (dupilumab) recommended for expanded EU approval by the CHMP to treat children as young as six months old with severe atopic dermatitis
Communiqué de presse: Le CHMP recommande l’extension des indications de Dupixent® (dupilumab) dans l’UE au traitement de la dermatite atopique sévère du jeune enfant à partir de 6 mois
06:00am, Friday, 27'th Jan 2023 GlobeNewswire Inc.
Le CHMP recommande l’extension des indications de Dupixent® (dupilumab) dans l’UE au traitement de la dermatite atopique sévère du jeune enfant à partir de 6 mois
Communiqué de presse : Le NEJM publie des données de phase III sur l’efanesoctocog alpha une fois par semaine qui illustrent son potentiel à transformer le traitement de l’hémophilie A
10:30pm, Wednesday, 25'th Jan 2023 GlobeNewswire Inc.
Press Release: NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating its potential to transform the treatment landscape for people with hemophilia A
10:30pm, Wednesday, 25'th Jan 2023 GlobeNewswire Inc.
Should Value Investors Buy Banco Santander (SAN) Stock?
02:40pm, Wednesday, 18'th Jan 2023 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Should Value Investors Buy Banco Santander (SAN) Stock?
11:19am, Wednesday, 18'th Jan 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Sanofi: Information concerning the total number of voting rights and shares – December 2022
07:44pm, Tuesday, 17'th Jan 2023 GlobeNewswire Inc.
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement
Sanofi: Informations relatives au nombre de droits de vote et d'actions – Decembre 2022
07:44pm, Tuesday, 17'th Jan 2023 GlobeNewswire Inc.
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marc
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns than research
06:40pm, Saturday, 14'th Jan 2023 MarketWatch
Drug companies say they need to raise prices on cancer drugs and other treatments to fund research. But they already spend more on stock buybacks and dividends.
Press Release: Sanofi Ventures announces multi-year capital commitment from Sanofi, increasing evergreen fund to $750M
04:30pm, Wednesday, 11'th Jan 2023 GlobeNewswire Inc.
Sanofi Ventures announces multi-year capital commitment from Sanofi, increasing evergreen fund to $750M
Communiqué de presse: Sanofi Ventures annonce un engagement de capital pluriannuel de la part de Sanofi, qui portera à 750 millions de dollars le capital de son fonds evergreen
04:30pm, Wednesday, 11'th Jan 2023 GlobeNewswire Inc.
Sanofi Ventures annonce un engagement de capital pluriannuel de la part de Sanofi, qui portera à 750 millions de dollars le capital de son fonds evergreen
Should Value Investors Buy Itau Unibanco (ITUB) Stock?
02:40pm, Wednesday, 11'th Jan 2023 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Communiqué de presse: La FDA accepte d’examiner la demande de licence pour le nirsevimab, première option de protection contre le VRS pour tous les nourrissons
07:00am, Thursday, 05'th Jan 2023 GlobeNewswire Inc.
La FDA accepte d’examiner la demande de licence pour le nirsevimab, première option de protection contre le VRS pour tous les nourrissons
